Humana (NYSE:HUM) Price Target Cut to $200.00 by Analysts at Truist Financial

Humana (NYSE:HUM) had its price target reduced by Truist Financial from $285.00 to $200.00 in a report issued on Tuesday, Marketbeat reports. They currently have a hold rating on the insurance provider’s stock.

HUM has been the subject of a number of other research reports. UBS Group cut their target price on shares of Humana from $285.00 to $195.00 and set a “neutral” rating for the company in a research report on Thursday, February 12th. Wells Fargo & Company cut shares of Humana from an “overweight” rating to a “cautious” rating in a research note on Wednesday, January 7th. Deutsche Bank Aktiengesellschaft set a $180.00 price objective on shares of Humana and gave the stock a “hold” rating in a report on Friday. Sanford C. Bernstein reissued an “outperform” rating and set a $344.00 target price on shares of Humana in a report on Tuesday, January 6th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research report on Thursday, January 22nd. Seven equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat, Humana presently has an average rating of “Hold” and an average price target of $232.13.

Humana Stock Performance

NYSE:HUM opened at $184.72 on Tuesday. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.00 and a quick ratio of 2.02. The business has a fifty day simple moving average of $241.89 and a two-hundred day simple moving average of $260.12. Humana has a 1 year low of $169.61 and a 1 year high of $315.35. The company has a market capitalization of $22.22 billion, a P/E ratio of 18.81, a P/E/G ratio of 1.96 and a beta of 0.44.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. The firm had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.The business’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, analysts expect that Humana will post 16.47 earnings per share for the current year.

Institutional Investors Weigh In On Humana

Hedge funds have recently bought and sold shares of the stock. PDT Partners LLC bought a new position in Humana in the fourth quarter valued at $2,431,000. DV Equities LLC purchased a new position in shares of Humana in the 4th quarter worth about $43,000. EFG International AG bought a new position in shares of Humana during the 4th quarter valued at about $857,000. BCV Asset Management Inc. purchased a new position in shares of Humana during the 4th quarter valued at about $60,967,000. Finally, Cetera Investment Advisers raised its holdings in shares of Humana by 2.1% during the 4th quarter. Cetera Investment Advisers now owns 12,815 shares of the insurance provider’s stock valued at $3,282,000 after buying an additional 261 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.